Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| KFHEALTH-D | +17.43% | +1.98% | +4.42% | +7.04% | +6.33% | +22.00% | +21.47% | +28.58% | +15.95% | +18.82% |
| BCARERMF | +14.68% | +1.24% | +4.80% | +5.42% | +6.60% | +19.34% | +23.35% | +35.25% | +7.62% | +7.18% |
| KKP GHC-D | +10.07% | +2.04% | +4.77% | +5.32% | +3.27% | +16.62% | +19.92% | +41.99% | +14.54% | +16.29% |
| SCBIHEALTH(E) | +10.12% | +1.06% | +4.43% | +4.74% | +7.71% | +23.59% | +16.09% | +25.91% | −46.80% | −52.38% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| KFHEALTH-D | KKP GHC-D | |
|---|---|---|
| Held by both | ||
 Eli Lilly and Co | 7.92% | 9.51% |
 Johnson & Johnson | 6.24% | 7.70% |
 ABBVIE | 7.23% | 4.88% |
 AstraZeneca | 4.06% | 3.67% |
 Thermo Fisher | 4.56% | 3.31% |
 Unitedhealth Group | 3.27% | 4.22% |
 Novartis | 4.46% | 2.70% |
 Merck & | 5.25% | 2.32% |
| Only in KFHEALTH-D | ||
 Abbott Laboratories | 2.87% | N/A |
 Danaher | 2.87% | N/A |
| Only in KKP GHC-D | ||
 Roche | N/A | 2.65% |
 argenx | N/A | 2.42% |
30 Dec 2025 → 29 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| KFHEALTH-D | +17.43% | 16.35% | 1.07 |
| BCARERMF | +14.68% | 16.03% | 0.92 |
| KKP GHC-D | +10.07% | 16.81% | 0.60 |
| SCBIHEALTH(E) | +10.12% | 17.35% | 0.58 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | KFHEALTH-D | BCARERMF | KKP GHC-D | SCBIHEALTH(E) |
|---|---|---|---|---|
Fund details | ||||
| Fund size | 2,984 million | 8,627 million | 111 million | 30.55 million |
| Inception date | 1 Aug 2014 | 19 May 2015 | 12 Mar 2008 | 29 Jun 2021 |
| Master fund | JPMorgan Funds - Global Healthcare Fund | Wellington Global Health Care Equity Fund | Janus Henderson Global Life Sciences Fund | BNP Paribas Funds Health Care Innovators |
| Dividend policy | Pays | Does not pay | Pays | Does not pay |
Risk and currency hedging | ||||
| Risk level | 7 | 7 | 7 | 7 |
| Hedging policy | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | 0.00% | 45.53% | 100.27% | 82.39% |
Minimum purchase and redemption | ||||
| First purchase | 500 THB | 500 THB | 1,000 THB | 1 THB |
| Subsequent purchase | 500 THB | 500 THB | 1,000 THB | 1 THB |
| Redemption (amount) | 500 THB | No minimum | No minimum | 1 THB |
| Redemption (units) | 50 units | No minimum | No minimum | No minimum |
| Balance (amount) | No minimum | No minimum | No minimum | 1 THB |
| Balance (units) | 50 units | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | 15:30 | 15:30 | 15:30 | 15:30 |
| Redeem before | 14:30 | 15:30 | 15:30 | 15:30 |
| Redemption paid | T+4 | T+4 | T+4 | T+4 |
